CCN2 and rheumatoid arthritis: It was found that expressions of Tumor-necrosis factor receptor-associated factor 1 (TRAF1) and connective tissue growth factor (CTGF) were significantly increased in osteoarthritis (OA) and RA chondrocytes following decitabine treatment [23].